The FDA granted Priority Review to the supplemental BLA (sBLA) for efgartigimod alfa-fcab for the treatment of adults with acetylcholine receptor antibody (AChR-Ab) seronegative generalized myasthenia ...

Global meningitis incidence and mortality declined since 1990, yet progress remains insufficient to meet the WHO 2030 vaccine-preventable targets.

Adults aged 65 and older receiving high-dose influenza vaccine show a lower risk for Alzheimer dementia compared with those receiving standard doses.

New consensus recommendations were developed to provide a framework for screening and treating tardive dyskinesia in a long-term care setting.

Christopher Ranch and Garland brand peeled garlic are recalled by Tops Markets because of a risk for Clostridium botulinum and life-threatening illness.

As CDC staffing difficulties continue under the current administration, the CDC announces a plan to pause various lab testing services.

CTAHN leads to acute management changes in a minority of patients, with the highest diagnostic yield found in stroke and headache cases.

A combination of physical therapy and transcutaneous electrical nerve stimulation reduces movement-based pain in fibromyalgia.

Suicidality at the time of focal epilepsy diagnosis is associated with a more than 2-fold increased risk for future antiseizure medication resistance.

A digital cognitive behavioral therapy treatment for cardiac anxiety appears to be effective among patients after myocardial infarction.

Among patients with OSA, the risk for severe COVID-19 does not differ among those who are adherent vs nonadherent to CPAP.

Automatic transvenous phrenic nerve stimulation demonstrates high nightly use and therapy adherence in adults with central sleep apnea.